{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal ALLO-ASC",
            "NStudiesAvail": 430108,
            "NStudiesFound": 22,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 22,
            "FieldList": [
                  "BriefSummary",
                  "BriefTitle",
                  "CentralContactEMail",
                  "CentralContactName",
                  "CentralContactPhone",
                  "CentralContactPhoneExt",
                  "CentralContactRole",
                  "CollaboratorClass",
                  "CollaboratorName",
                  "CompletionDate",
                  "CompletionDateType",
                  "Condition",
                  "ConditionAncestorId",
                  "ConditionAncestorTerm",
                  "ConditionBrowseBranchAbbrev",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "BriefSummary": [
                              "Main purpose of this study is to evaluate efficacy and safety of allogenic adipose-derived mesenchymal stem cells(ALLO-ASC) in treatment of tendon injury. ALLO-ASC will be administrated to the patients with lateral epicondylitis by ultrasonographic guided injection."
                        ],
                        "BriefTitle": [
                              "Treatment of Tendon Injury Using Mesenchymal Stem Cells"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [
                              "OTHER"
                        ],
                        "CollaboratorName": [
                              "Medical Research Collaborating Center, Seoul, Korea"
                        ],
                        "CompletionDate": [
                              "April 2018"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Lateral Epicondylitis"
                        ],
                        "ConditionAncestorId": [
                              "D000070639",
                              "D000052256",
                              "D000009135",
                              "D000009140",
                              "D000001134",
                              "D000014947"
                        ],
                        "ConditionAncestorTerm": [
                              "Elbow Tendinopathy",
                              "Tendinopathy",
                              "Muscular Diseases",
                              "Musculoskeletal Diseases",
                              "Arm Injuries",
                              "Wounds and Injuries"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC05",
                              "BC26",
                              "All",
                              "BC10"
                        ],
                        "NCTId": [
                              "NCT01856140"
                        ]
                  },
                  {
                        "Rank": 2,
                        "BriefSummary": [
                              "The aim of this study is to evaluate the efficacy and safety of intra-tendon injection of allogeneic adipose-derived mesenchymal stem cells (Allo-ASC) in intractable common extensor tendinosis patients in comparison with a control treatment."
                        ],
                        "BriefTitle": [
                              "Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC)"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [
                              "OTHER_GOV"
                        ],
                        "CollaboratorName": [
                              "Korea Health Industry Development Institute"
                        ],
                        "CompletionDate": [
                              "December 30, 2021"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Lateral Epicondylitis"
                        ],
                        "ConditionAncestorId": [
                              "D000070639",
                              "D000052256",
                              "D000009135",
                              "D000009140",
                              "D000001134",
                              "D000014947"
                        ],
                        "ConditionAncestorTerm": [
                              "Elbow Tendinopathy",
                              "Tendinopathy",
                              "Muscular Diseases",
                              "Musculoskeletal Diseases",
                              "Arm Injuries",
                              "Wounds and Injuries"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC05",
                              "BC26",
                              "All",
                              "BC10"
                        ],
                        "NCTId": [
                              "NCT03449082"
                        ]
                  },
                  {
                        "Rank": 3,
                        "BriefSummary": [
                              "Purpose: The investigators aimed to investigate the safety and efficacy in the treatment of fecal incontinence by injection of ALLO-ASC into the anal sphincter.\n\nMethod\n\nSafety test of allogenic ASCs injection\nEfficacy test of allogenic ASCs injection"
                        ],
                        "BriefTitle": [
                              "Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "June 30, 2017"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Fecal Incontinence"
                        ],
                        "ConditionAncestorId": [
                              "D000012002",
                              "D000007410",
                              "D000005767",
                              "D000004066"
                        ],
                        "ConditionAncestorTerm": [
                              "Rectal Diseases",
                              "Intestinal Diseases",
                              "Gastrointestinal Diseases",
                              "Digestive System Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC06",
                              "All"
                        ],
                        "NCTId": [
                              "NCT02384499"
                        ]
                  },
                  {
                        "Rank": 4,
                        "BriefSummary": [
                              "This is a phase 2 double-blind clinical study to evaluate the efficacy and Safety of ALLO-ASC-SHEET in subjects with Diabetic Wagner Grade II Foot Ulcers, compared to placebo therapy."
                        ],
                        "BriefTitle": [
                              "Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers"
                        ],
                        "CentralContactEMail": [
                              "yunjungchoi@anterogen.com"
                        ],
                        "CentralContactName": [
                              "Yun Jung Choi, PM",
                              "Jessi Choi, PM"
                        ],
                        "CentralContactPhone": [
                              "82 10 9199 0164",
                              "82 10 9199 0164"
                        ],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [
                              "Contact",
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "December 2022"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Diabetic Foot Ulcer"
                        ],
                        "ConditionAncestorId": [
                              "D000010335",
                              "D000003925",
                              "D000014652",
                              "D000002318",
                              "D000007871",
                              "D000012883",
                              "D000012871",
                              "D000048909",
                              "D000003920",
                              "D000004700",
                              "D000003929",
                              "D000005534"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes",
                              "Diabetic Angiopathies",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Leg Ulcer",
                              "Skin Ulcer",
                              "Skin Diseases",
                              "Diabetes Complications",
                              "Diabetes Mellitus",
                              "Endocrine System Diseases",
                              "Diabetic Neuropathies",
                              "Foot Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC14",
                              "BC17",
                              "BC19",
                              "All",
                              "BC23",
                              "BC18",
                              "BC10",
                              "BC05"
                        ],
                        "NCTId": [
                              "NCT04497805"
                        ]
                  },
                  {
                        "Rank": 5,
                        "BriefSummary": [
                              "This is a phase II single-blinded study to evaluate the efficacy and safety of ALLO-ASC-DFU in patients with Diabetic Foot Ulcer, compared to standard therapy."
                        ],
                        "BriefTitle": [
                              "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "October 2016"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Diabetic Foot Ulcer"
                        ],
                        "ConditionAncestorId": [
                              "D000010335",
                              "D000003925",
                              "D000014652",
                              "D000002318",
                              "D000007871",
                              "D000012883",
                              "D000012871",
                              "D000048909",
                              "D000003920",
                              "D000004700",
                              "D000003929",
                              "D000005534"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes",
                              "Diabetic Angiopathies",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Leg Ulcer",
                              "Skin Ulcer",
                              "Skin Diseases",
                              "Diabetes Complications",
                              "Diabetes Mellitus",
                              "Endocrine System Diseases",
                              "Diabetic Neuropathies",
                              "Foot Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC14",
                              "BC17",
                              "BC19",
                              "All",
                              "BC23",
                              "BC18",
                              "BC10",
                              "BC05"
                        ],
                        "NCTId": [
                              "NCT02619877"
                        ]
                  },
                  {
                        "Rank": 6,
                        "BriefSummary": [
                              "This is a phase 2 double-blind clinical study to evaluate the efficacy and Safety of ALLO-ASC-SHEET in subjects with Diabetic Foot Ulcers, compared to placebo therapy."
                        ],
                        "BriefTitle": [
                              "Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Foot Ulcers"
                        ],
                        "CentralContactEMail": [
                              "armstrong@usa.net"
                        ],
                        "CentralContactName": [
                              "David G. Armstrong, MD.Ph D."
                        ],
                        "CentralContactPhone": [
                              "(+1)5203059393"
                        ],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "December 30, 2022"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Diabetic Foot Ulcer"
                        ],
                        "ConditionAncestorId": [
                              "D000010335",
                              "D000003925",
                              "D000014652",
                              "D000002318",
                              "D000007871",
                              "D000012883",
                              "D000012871",
                              "D000048909",
                              "D000003920",
                              "D000004700",
                              "D000003929",
                              "D000005534"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes",
                              "Diabetic Angiopathies",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Leg Ulcer",
                              "Skin Ulcer",
                              "Skin Diseases",
                              "Diabetes Complications",
                              "Diabetes Mellitus",
                              "Endocrine System Diseases",
                              "Diabetic Neuropathies",
                              "Foot Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC14",
                              "BC17",
                              "BC19",
                              "All",
                              "BC23",
                              "BC18",
                              "BC10",
                              "BC05"
                        ],
                        "NCTId": [
                              "NCT03754465"
                        ]
                  },
                  {
                        "Rank": 7,
                        "BriefSummary": [
                              "This clinical trial is a Phase II controlled, parallel, open-label trial, designed to test the efficacy and safety of ALLO-ASC-DFU and conventional therapy in Deep Second-degree burn wound subjects."
                        ],
                        "BriefTitle": [
                              "A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "June 2023"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Burn Injury"
                        ],
                        "ConditionAncestorId": [],
                        "ConditionAncestorTerm": [],
                        "ConditionBrowseBranchAbbrev": [
                              "BC26",
                              "All"
                        ],
                        "NCTId": [
                              "NCT02619851"
                        ]
                  },
                  {
                        "Rank": 8,
                        "BriefSummary": [
                              "This is a phase III double-blind study to evaluate the efficacy and safety of ALLO-ASC-DFU in patients with Diabetic Foot Ulcer, compared to placebo therapy."
                        ],
                        "BriefTitle": [
                              "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers."
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "June 30, 2021"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Diabetic Foot Ulcer"
                        ],
                        "ConditionAncestorId": [
                              "D000010335",
                              "D000003925",
                              "D000014652",
                              "D000002318",
                              "D000007871",
                              "D000012883",
                              "D000012871",
                              "D000048909",
                              "D000003920",
                              "D000004700",
                              "D000003929",
                              "D000005534"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes",
                              "Diabetic Angiopathies",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Leg Ulcer",
                              "Skin Ulcer",
                              "Skin Diseases",
                              "Diabetes Complications",
                              "Diabetes Mellitus",
                              "Endocrine System Diseases",
                              "Diabetic Neuropathies",
                              "Foot Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC14",
                              "BC17",
                              "BC19",
                              "All",
                              "BC23",
                              "BC18",
                              "BC10",
                              "BC05"
                        ],
                        "NCTId": [
                              "NCT03370874"
                        ]
                  },
                  {
                        "Rank": 9,
                        "BriefSummary": [
                              "This is an open-label follow up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment in phase 1 clinical trial (ALLO-ASC-DFU-101) for 23 months."
                        ],
                        "BriefTitle": [
                              "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-101 Clinical Trial"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "July 31, 2017"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Diabetic Foot Ulcer"
                        ],
                        "ConditionAncestorId": [
                              "D000003925",
                              "D000014652",
                              "D000002318",
                              "D000007871",
                              "D000012883",
                              "D000012871",
                              "D000048909",
                              "D000003920",
                              "D000004700",
                              "D000003929",
                              "D000005534"
                        ],
                        "ConditionAncestorTerm": [
                              "Diabetic Angiopathies",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Leg Ulcer",
                              "Skin Ulcer",
                              "Skin Diseases",
                              "Diabetes Complications",
                              "Diabetes Mellitus",
                              "Endocrine System Diseases",
                              "Diabetic Neuropathies",
                              "Foot Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC14",
                              "BC17",
                              "BC19",
                              "All",
                              "BC23",
                              "BC18",
                              "BC10",
                              "BC05"
                        ],
                        "NCTId": [
                              "NCT03183726"
                        ]
                  },
                  {
                        "Rank": 10,
                        "BriefSummary": [
                              "This is an open-label follow up study to evaluate the safety for the subjects with ALLO-ASC-CD injection in phase 1 clinical trial (ALLO-ASC-CD-101) for 36 months."
                        ],
                        "BriefTitle": [
                              "A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "April 30, 2021"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Crohn Disease"
                        ],
                        "ConditionAncestorId": [
                              "D000015212",
                              "D000005759",
                              "D000005767",
                              "D000004066",
                              "D000007410"
                        ],
                        "ConditionAncestorTerm": [
                              "Inflammatory Bowel Diseases",
                              "Gastroenteritis",
                              "Gastrointestinal Diseases",
                              "Digestive System Diseases",
                              "Intestinal Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC06",
                              "All"
                        ],
                        "NCTId": [
                              "NCT03183661"
                        ]
                  },
                  {
                        "Rank": 11,
                        "BriefSummary": [
                              "Main purpose of this study is to evaluate efficacy of allogenic adipose-derived mesenchymal stem cells in treatment of tendon injury. ALLO-ASC will be administrated to the patients with supraspinatus partial thickness tear by ultrasonographic guided injection."
                        ],
                        "BriefTitle": [
                              "Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear)"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "April 10, 2018"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Rotator Cuff Tear"
                        ],
                        "ConditionAncestorId": [
                              "D000012421",
                              "D000014947",
                              "D000070599"
                        ],
                        "ConditionAncestorTerm": [
                              "Rupture",
                              "Wounds and Injuries",
                              "Shoulder Injuries"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC26",
                              "All"
                        ],
                        "NCTId": [
                              "NCT02298023"
                        ]
                  },
                  {
                        "Rank": 12,
                        "BriefSummary": [
                              "This is an open-label follow up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment in phase 2 clinical trial (ALLO-ASC-DFU-201) for 23 months."
                        ],
                        "BriefTitle": [
                              "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical Trial"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "August 31, 2018"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Diabetic Foot Ulcer"
                        ],
                        "ConditionAncestorId": [
                              "D000003925",
                              "D000014652",
                              "D000002318",
                              "D000007871",
                              "D000012883",
                              "D000012871",
                              "D000048909",
                              "D000003920",
                              "D000004700",
                              "D000003929",
                              "D000005534"
                        ],
                        "ConditionAncestorTerm": [
                              "Diabetic Angiopathies",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Leg Ulcer",
                              "Skin Ulcer",
                              "Skin Diseases",
                              "Diabetes Complications",
                              "Diabetes Mellitus",
                              "Endocrine System Diseases",
                              "Diabetic Neuropathies",
                              "Foot Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC14",
                              "BC17",
                              "BC19",
                              "All",
                              "BC23",
                              "BC18",
                              "BC10",
                              "BC05"
                        ],
                        "NCTId": [
                              "NCT03183804"
                        ]
                  },
                  {
                        "Rank": 13,
                        "BriefSummary": [
                              "The purpose of this study is to evaluate safety and efficacy of tissue engineered construct based on allogeneic cultured adipose-derived multipotent mesenchymal stromal cells (ALLO-ADSCs) and platelet-poor plasma fibrin hydrogel to treat patients with 2-B and 3- degree burn wounds"
                        ],
                        "BriefTitle": [
                              "Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs)"
                        ],
                        "CentralContactEMail": [
                              "V.Melnyk@ilaya.ua",
                              "N.Olijnyk@ilaya.ua"
                        ],
                        "CentralContactName": [
                              "Volodymyr S. Melnyk, MD, DSc",
                              "Nataliia M. Olijnyk, PhD"
                        ],
                        "CentralContactPhone": [
                              "+380679337461",
                              "+380934040116"
                        ],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [
                              "Contact",
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "December 26, 2018"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Second- or Third-degree Burns"
                        ],
                        "ConditionAncestorId": [
                              "D000014947"
                        ],
                        "ConditionAncestorTerm": [
                              "Wounds and Injuries"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC26",
                              "All"
                        ],
                        "NCTId": [
                              "NCT03113747"
                        ]
                  },
                  {
                        "Rank": 14,
                        "BriefSummary": [
                              "This is a phase I/II open-label study to evaluate the efficacy and safety of ALLO-ASC-DFU in patients with Dystrophic Epidermolysis Bullosa."
                        ],
                        "BriefTitle": [
                              "Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa"
                        ],
                        "CentralContactEMail": [
                              "kimsc@yuhs.ac"
                        ],
                        "CentralContactName": [
                              "Su Chan Kim, PhD."
                        ],
                        "CentralContactPhone": [
                              "+82 2 2019-3362"
                        ],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "December 2017"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Dystrophic Epidermolysis Bullosa"
                        ],
                        "ConditionAncestorId": [
                              "D000012868",
                              "D000000013",
                              "D000012873",
                              "D000030342",
                              "D000012871",
                              "D000012872",
                              "D000003095",
                              "D000003240"
                        ],
                        "ConditionAncestorTerm": [
                              "Skin Abnormalities",
                              "Congenital Abnormalities",
                              "Skin Diseases, Genetic",
                              "Genetic Diseases, Inborn",
                              "Skin Diseases",
                              "Skin Diseases, Vesiculobullous",
                              "Collagen Diseases",
                              "Connective Tissue Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC16",
                              "BC17",
                              "All",
                              "BC05",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT02579369"
                        ]
                  },
                  {
                        "Rank": 15,
                        "BriefSummary": [
                              "This is a phase I study to evaluate the safety of ALLO-ASC-CD for the treatment of crohn' disease. ALLO-ASC-CD is intravenous infusion containing allogenic adipose-derived mesenchymal stem cells."
                        ],
                        "BriefTitle": [
                              "A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease"
                        ],
                        "CentralContactEMail": [
                              "kimwonho@yuhs.ac"
                        ],
                        "CentralContactName": [
                              "Won Ho Kim, MD., PhD"
                        ],
                        "CentralContactPhone": [
                              "82-2-2228-1951"
                        ],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "June 2023"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Crohn's Disease"
                        ],
                        "ConditionAncestorId": [
                              "D000015212",
                              "D000005759",
                              "D000005767",
                              "D000004066",
                              "D000007410"
                        ],
                        "ConditionAncestorTerm": [
                              "Inflammatory Bowel Diseases",
                              "Gastroenteritis",
                              "Gastrointestinal Diseases",
                              "Digestive System Diseases",
                              "Intestinal Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC06",
                              "All"
                        ],
                        "NCTId": [
                              "NCT02580617"
                        ]
                  },
                  {
                        "Rank": 16,
                        "BriefSummary": [
                              "This is a phase I open-label study to evaluate the safety of ALLO-ASC-DFU in diabetic foot ulcers patients. ALLO-ASC-DFU is a hydrogel sheet containing allogenic adipose-derived mesenchymal stem cells. Adipose-derived stem cells have anti-inflammatory effect and release growth factors such as vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), which can enhance wound healing and regeneration of new tissue, finally may provide an new option in treating a diabetic foot ulcer."
                        ],
                        "BriefTitle": [
                              "Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot Ulcers"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "July 2015"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Diabetic Foot Ulcer"
                        ],
                        "ConditionAncestorId": [
                              "D000010335",
                              "D000003925",
                              "D000014652",
                              "D000002318",
                              "D000007871",
                              "D000012883",
                              "D000012871",
                              "D000048909",
                              "D000003920",
                              "D000004700",
                              "D000003929",
                              "D000005534"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes",
                              "Diabetic Angiopathies",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Leg Ulcer",
                              "Skin Ulcer",
                              "Skin Diseases",
                              "Diabetes Complications",
                              "Diabetes Mellitus",
                              "Endocrine System Diseases",
                              "Diabetic Neuropathies",
                              "Foot Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC14",
                              "BC17",
                              "BC19",
                              "All",
                              "BC23",
                              "BC18",
                              "BC10",
                              "BC05"
                        ],
                        "NCTId": [
                              "NCT02394886"
                        ]
                  },
                  {
                        "Rank": 17,
                        "BriefSummary": [
                              "This is a phase I study to evaluate the safety of ALLO-ASC-DFU for the treatment of deep second-degree burn wound patients. ALLO-ASC-DFU is a hydrogel sheet containing allogenic adipose-derived mesenchymal stem cells. Adipose-derived stem cells release growth factors such as vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), which can enhance wound healing and regeneration of new tissue, finally may provide a new option in treating a burn."
                        ],
                        "BriefTitle": [
                              "A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "October 2015"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Burn"
                        ],
                        "ConditionAncestorId": [
                              "D000014947"
                        ],
                        "ConditionAncestorTerm": [
                              "Wounds and Injuries"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC26",
                              "All"
                        ],
                        "NCTId": [
                              "NCT02394873"
                        ]
                  },
                  {
                        "Rank": 18,
                        "BriefSummary": [
                              "This is an open-label follow up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment in phase 1 clinical trial(ALLO-ASC-BI-101) for 23 months."
                        ],
                        "BriefTitle": [
                              "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "December 2017"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Burn"
                        ],
                        "ConditionAncestorId": [],
                        "ConditionAncestorTerm": [],
                        "ConditionBrowseBranchAbbrev": [
                              "BC26",
                              "All"
                        ],
                        "NCTId": [
                              "NCT03183622"
                        ]
                  },
                  {
                        "Rank": 19,
                        "BriefSummary": [
                              "This is an open-label follow up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment in phase 2 clinical trial (ALLO-ASC-BI-201) for 23 months."
                        ],
                        "BriefTitle": [
                              "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-201 Clinical Trial"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "June 2023"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Burn"
                        ],
                        "ConditionAncestorId": [],
                        "ConditionAncestorTerm": [],
                        "ConditionBrowseBranchAbbrev": [
                              "BC26",
                              "All"
                        ],
                        "NCTId": [
                              "NCT03183648"
                        ]
                  },
                  {
                        "Rank": 20,
                        "BriefSummary": [
                              "This is a phase III double-blind study to evaluate the efficacy and safety of ALLO-ASC-DFU in patients with Diabetic Wagner grade 2 Foot Ulcer, compared to placebo therapy."
                        ],
                        "BriefTitle": [
                              "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers."
                        ],
                        "CentralContactEMail": [
                              "pshan@kumc.or.kr"
                        ],
                        "CentralContactName": [
                              "SeungKyu Han, MD. Ph D"
                        ],
                        "CentralContactPhone": [
                              "+82-02-2626-3333"
                        ],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "December 31, 2021"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Diabetic Foot Ulcer"
                        ],
                        "ConditionAncestorId": [
                              "D000010335",
                              "D000003925",
                              "D000014652",
                              "D000002318",
                              "D000007871",
                              "D000012883",
                              "D000012871",
                              "D000048909",
                              "D000003920",
                              "D000004700",
                              "D000003929",
                              "D000005534"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes",
                              "Diabetic Angiopathies",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Leg Ulcer",
                              "Skin Ulcer",
                              "Skin Diseases",
                              "Diabetes Complications",
                              "Diabetes Mellitus",
                              "Endocrine System Diseases",
                              "Diabetic Neuropathies",
                              "Foot Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC14",
                              "BC17",
                              "BC19",
                              "All",
                              "BC23",
                              "BC18",
                              "BC10",
                              "BC05"
                        ],
                        "NCTId": [
                              "NCT04569409"
                        ]
                  },
                  {
                        "Rank": 21,
                        "BriefSummary": [
                              "This is an open-label follow up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment in phase 1/2 clinical trial(ALLO-ASC-EB-101) for 24 months."
                        ],
                        "BriefTitle": [
                              "A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial"
                        ],
                        "CentralContactEMail": [
                              "kimsc@yuhs.ac"
                        ],
                        "CentralContactName": [
                              "Su Chan Kim, PhD"
                        ],
                        "CentralContactPhone": [
                              "82 2 2019 3362"
                        ],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "June 2020"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Dystrophic Epidermolysis Bullosa"
                        ],
                        "ConditionAncestorId": [
                              "D000012868",
                              "D000000013",
                              "D000012873",
                              "D000030342",
                              "D000012871",
                              "D000012872",
                              "D000003095",
                              "D000003240"
                        ],
                        "ConditionAncestorTerm": [
                              "Skin Abnormalities",
                              "Congenital Abnormalities",
                              "Skin Diseases, Genetic",
                              "Genetic Diseases, Inborn",
                              "Skin Diseases",
                              "Skin Diseases, Vesiculobullous",
                              "Collagen Diseases",
                              "Connective Tissue Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC16",
                              "BC17",
                              "All",
                              "BC05",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT03183934"
                        ]
                  },
                  {
                        "Rank": 22,
                        "BriefSummary": [
                              "After confirming eligibility, a single subject with two selected target lesions will receive both ALLO-ASC-SHEET and Vehicle control, one target lesion for each IP (one target lesion for ALLO-ASC-SHEET and the other target for Vehicle control), and which lesion to apply which IP will be determined randomly at the time of enrollment using IWRS."
                        ],
                        "BriefTitle": [
                              "Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "February 29, 2024"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Dystrophic Epidermolysis Bullosa"
                        ],
                        "ConditionAncestorId": [
                              "D000012868",
                              "D000000013",
                              "D000012873",
                              "D000030342",
                              "D000012871",
                              "D000012872",
                              "D000003095",
                              "D000003240"
                        ],
                        "ConditionAncestorTerm": [
                              "Skin Abnormalities",
                              "Congenital Abnormalities",
                              "Skin Diseases, Genetic",
                              "Genetic Diseases, Inborn",
                              "Skin Diseases",
                              "Skin Diseases, Vesiculobullous",
                              "Collagen Diseases",
                              "Connective Tissue Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC16",
                              "BC17",
                              "All",
                              "BC05",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT05157958"
                        ]
                  }
            ]
      }
}